These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1167 related items for PubMed ID: 12096833
1. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF. J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833 [Abstract] [Full Text] [Related]
2. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. Xing L, Carlson L, Story B, Tai Z, Keng P, Siebenlist U, Boyce BF. J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403 [Abstract] [Full Text] [Related]
3. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [Abstract] [Full Text] [Related]
4. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR. J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992 [Abstract] [Full Text] [Related]
5. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T. J Bone Miner Res; 2000 Sep 01; 15(9):1766-75. PubMed ID: 10976996 [Abstract] [Full Text] [Related]
6. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H. J Immunol; 2003 Nov 15; 171(10):5130-9. PubMed ID: 14607912 [Abstract] [Full Text] [Related]
7. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K, Kudo A. J Bone Miner Res; 2005 May 15; 20(5):840-7. PubMed ID: 15824857 [Abstract] [Full Text] [Related]
8. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. Sugatani T, Alvarez UM, Hruska KA. J Cell Biochem; 2003 Sep 01; 90(1):59-67. PubMed ID: 12938156 [Abstract] [Full Text] [Related]
10. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT. J Bone Miner Res; 2001 Oct 01; 16(10):1787-94. PubMed ID: 11585342 [Abstract] [Full Text] [Related]
11. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population. Nagata N, Kitaura H, Yoshida N, Nakayama K. Bone; 2003 Oct 01; 33(4):721-32. PubMed ID: 14555278 [Abstract] [Full Text] [Related]
12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP. J Bone Miner Res; 2005 Sep 01; 20(9):1659-68. PubMed ID: 16059637 [Abstract] [Full Text] [Related]
13. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W, Bar-Shavit Z. J Bone Miner Res; 2002 Jul 01; 17(7):1211-8. PubMed ID: 12096834 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. J Exp Med; 2000 Jan 17; 191(2):275-86. PubMed ID: 10637272 [Abstract] [Full Text] [Related]
15. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. Karst M, Gorny G, Galvin RJ, Oursler MJ. J Cell Physiol; 2004 Jul 17; 200(1):99-106. PubMed ID: 15137062 [Abstract] [Full Text] [Related]
16. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. Bone; 1999 Nov 17; 25(5):517-23. PubMed ID: 10574571 [Abstract] [Full Text] [Related]
17. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Yamada T, Yamazaki H, Yamane T, Yoshino M, Okuyama H, Tsuneto M, Kurino T, Hayashi S, Sakano S. Blood; 2003 Mar 15; 101(6):2227-34. PubMed ID: 12411305 [Abstract] [Full Text] [Related]
18. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF. J Biol Chem; 2007 Jun 22; 282(25):18245-18253. PubMed ID: 17485464 [Abstract] [Full Text] [Related]